TINA SMITH: Open Payments
NPI 1336782978 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 99 payments from 25 companies in 2025. Trend: 2023 $943 · 2024 $1,997 · 2025 $2,137
Food & beverage: $2,137
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 14 | $335 |
| ABBVIE INC. | 14 | $264 |
| Neurocrine BioSciences, Inc. | 15 | $214 |
| PFIZER INC. | 15 | $159 |
| UCB, Inc. | 4 | $149 |
| Otsuka America Pharmaceutical, Inc. | 5 | $139 |
| TG Therapeutics, Inc. | 2 | $124 |
| ARGENX US, INC. | 4 | $105 |
| Alexion Pharmaceuticals, Inc. | 3 | $85 |
| Amneal Pharmaceuticals LLC | 3 | $69 |
Products named: NUPLAZID, INGREZZA, REXULTI, NURTEC ODT, BRIUMVI, QULIPTA, ULTOMIRIS, UBRELVY.
Industry payments across SC — which companies pay providers there.
